MightySat Rx pulse oximeter, a product of Masimo landed the European CE mark of approval to be used in clinical environments.
The device, which is available in three versions, features Masimo's SET Measure-Through Motion and Low Perfusion technology that's part of the company's clinical oximeters already common in hospitals worldwide.
Bluetooth-enabled versions of MightySat Rx allow clinicians to track and trend up to 12 hours of patient measurements on smart mobile devices, and to share that data via standard CSV files as well as transfer to Apple's Health app.
MightySat Rx enables accurate noninvasive spot-checking of oxygen saturation (SpO2) and pulse rate (PR) for adult and pediatric patients even during motion and low perfusion.
The MightySat Rx, Bluetooth and PVI version of the device also provides Pleth Variability Index (PVI), an indication of the changes in the perfusion index that occurs during respiratory cycles. "Many clinicians around the world rely on pulse oximetry as the fifth vital sign," stated Joe Kiani, Founder & CEO of Masimo.